
Carlos Ortiz, NP
Board-Certified Nurse Practitioner
Weight Management & Body Composition

Treatments
Weight Loss
A personalized online weight loss program from licensed providers, not a one-size-fits-all plan.
Convenient online care
Personalized treatment
Direct care team messaging
Medication home delivery
Ongoing expert guidance
Healthy habit support
Provider-guided care for a $79/month membership + cost of treatment.
Weight Loss
Personalized, once-weekly weight management injections prescribed by a licensed medical provider.
.webp&w=640&q=75)
Weight Loss
A GLP-1 receptor agonist that supports appetite regulation and sustainable weight loss through one hormone pathway.
$149/month
Any prescribed dose
+ Rejuva Meds membership
.webp&w=640&q=75)
Weight Loss
A dual GIP and GLP-1 receptor agonist that supports appetite regulation and metabolic health through two hormone pathways.
$249/month
Any prescribed dose
+ Rejuva Meds membership
Any Dose Program
One price. Any prescribed dose.
Simple, transparent pricing no matter what your dose.
Rejuva Meds does not manufacture compounded medications. Actual product appearance, concentration, labeling, and supply details may vary based on pharmacy and provider.

How it works
Most of the process happens online.
Step 1
Fill out a secure questionnaire covering your health history, symptoms, and goals.
Step 2
Your provider checks whether treatment is clinically appropriate for you.
Step 3
Your prescription goes to one of our licensed pharmacy partners and ships to your door in discreet packaging.
Step 4
Your provider monitors your progress, answers questions, and adjusts your plan as needed.
~30 lb
In the SURMOUNT-4 clinical trial, participants who completed an initial 36-week Tirzepatide treatment period and continued treatment achieved an average total weight reduction of 25.3% over 88 weeks.
Starting weight: 120 lb
Estimated Weight Loss at 88 Weeks
120 lb
90 lb
25.3%
Average total weight loss with continued Tirzepatide
These results are from a clinical study of an FDA-approved Tirzepatide product and have not been established for compounded Tirzepatide. Individual results may vary.
Your medication options
Semaglutide and Tirzepatide are both GLP-1 agonist medications, treatments that work like a natural hormone your body already makes to help control appetite. Your provider reviews your health history and goals to recommend which one, if either, fits you.
GLP-1 treatment is a class of prescription medication including GLP-1 (Semaglutide) and GLP-1 + GIP (Tirzepatide) - that works with your body's natural appetite signals, helping you feel full sooner, stay satisfied longer, and reduce the constant food noise. At Rejuva Meds, every protocol is reviewed by a licensed provider and built around you.
Semaglutide is a GLP-1 receptor agonist Tirzepatide is a dual GIP and GLP-1 receptor agonist. Both are designed to support appetite regulation and long-term weight management, but they work through different receptor pathways. Your provider reviews your health history and goals to determine what may be appropriate for you.
GLP 1 treatment may be considered for adults working toward provider-guided weight management who meet clinical criteria. Eligibility is determined by a licensed provider based on your medical history, current health, and goals. Treatment isn't right for everyone - that's why every plan begins with a provider review, not a checkout.
You complete a quick clinical intake, share your medical history, and connect with a licensed provider. If approved, your medication is prepared by a partner pharmacy and shipped directly. Your provider stays involved as your dosing is titrated and adjusted over time.
Side effects vary by person. Common effects may include nausea, constipation, diarrhea, appetite changes, or digestive discomfort, especially while your body adjusts. Your provider reviews your medical history, explains what to watch for, and can adjust your protocol if needed.
No. The medications prescribed through Rejuva Meds are compounded preparations, and compounded medications are not FDA-approved. The FDA does not review compounded preparations for safety, effectiveness, or manufacturing quality before they’re marketed. They are prescribed by a licensed clinician and prepared by a licensed pharmacy when determined appropriate for you. Read full safety information
Compare your options
Semaglutide Compound Tirzepatide | Semaglutide Compound Tirzepatide | |
|---|---|---|
Mechanism of action | Mimics the GLP-1 hormone to reduce appetite, increase fullness, and slow how quickly food leaves your stomach Activates both the GIP and GLP-1 receptors to reduce appetite, increase fullness, slow gastric emptying, and support healthy blood sugar | Mimics the GLP-1 hormone to reduce appetite, increase fullness, and slow how quickly food leaves your stomach Activates both the GIP and GLP-1 receptors to reduce appetite, increase fullness, slow gastric emptying, and support healthy blood sugar |
Dosage & administration | Once-weekly shot just under the skin, self-administered at home; starts at a low dose, increased gradually based on how you respond Once-weekly shot just under the skin, self-administered at home; starts at a low dose, increased gradually based on how you respond | Once-weekly shot just under the skin, self-administered at home; starts at a low dose, increased gradually based on how you respond Once-weekly shot just under the skin, self-administered at home; starts at a low dose, increased gradually based on how you respond |
FDA status | FDA-approved under brand names including Wegovy and Ozempic for specific approved uses FDA-approved under brand names including Zepbound (chronic weight management) and Mounjaro (type 2 diabetes) | FDA-approved under brand names including Wegovy and Ozempic for specific approved uses FDA-approved under brand names including Zepbound (chronic weight management) and Mounjaro (type 2 diabetes) |
Expected results timeline | Many patients notice reduced appetite within the first few weeks; meaningful weight loss typically develops over several months with consistent treatment. Semaglutide helped individuals lose an average of 15% of their body weight over 68 weeks in clinical studies. Many patients notice reduced appetite within the first few weeks; meaningful weight loss typically develops over several months with consistent treatment. Tirzepatide helped individuals lose an average of 20% of their body weight over 68 weeks in clinical studies. | Many patients notice reduced appetite within the first few weeks; meaningful weight loss typically develops over several months with consistent treatment. Semaglutide helped individuals lose an average of 15% of their body weight over 68 weeks in clinical studies. Many patients notice reduced appetite within the first few weeks; meaningful weight loss typically develops over several months with consistent treatment. Tirzepatide helped individuals lose an average of 20% of their body weight over 68 weeks in clinical studies. |
No one-size-fits-all solution. The right treatment depends on your health history, goals, and provider evaluation.
Who reviews your case

Board-Certified Nurse Practitioner
Weight Management & Body Composition

Board-Certified Nurse Practitioner
Weight Management & Body Composition
Board-certified medical providers
Evidence-based medicine
Ongoing follow-up care
HIPAA-compliant telehealth
Pricing
Medical Evaluation
Ongoing Follow-ups
Personalized Treatment Guidance
Shipping & Handling
Home Injection Kit
24/7 Messaging Access
Same price at every dose
Same price at every dose
Same price at every dose
Same price at every dose
Depending on your plan, you may be able to use HSA or FSA funds for eligible services. Membership and treatment costs are stated plainly, with no hidden fees. Cancel your membership any time.
Testimonials
Trust
HIPAA compliant
Licensed telehealth provider, Florida
Licensed U.S. pharmacies
Secure patient portal
.jpg&w=3840&q=75)
Ready when you are.
Licensed medical providers
HIPAA compliant
Licensed U.S. pharmacies
Personalized telehealth for weight loss, longevity, and muscle recovery, delivered by licensed providers.
Treatment
2026 Rejuva Meds, LLC. All rights reserved. Designed and Developed by Kodexo Labs
